Dinh:Thesis Overview: Difference between revisions
Jump to navigation
Jump to search
>Dinh (Created page with "===Samples: Data analysis === * ''' Salk's Human Tissues Whole Genome Bisulfite Sequencing '''' ** Paper: Not out yet * ''' Human peripheral mononuclear cells trio - type 2 di...") |
>Dinh mNo edit summary |
||
Line 9: | Line 9: | ||
===Samples: Data generation === | ===Samples: Data generation === | ||
* ''' Early definitive endoderm differentiation (Song's 3-days protocol)''' | * ''' Early definitive endoderm differentiation (Song's 3-days protocol)''' | ||
** {| class="wikitable" | |||
| align="center" style="background:#f0f0f0;"|'''Tube ID''' | |||
| align="center" style="background:#f0f0f0;"|'''Sample''' | |||
| align="center" style="background:#f0f0f0;"|'''Concentration (QUBIT, ng/ul)''' | |||
|- | |||
| MA-16||H1 p54 Control TeSR||57.0 | |||
|- | |||
| MA-17||H1 p54 Activin-A||40.1 | |||
|- | |||
| AP-13||H1 p47 Control TeSR||85.0 | |||
|- | |||
| AP-14||H1 p47 BMP-4||49.4 | |||
|- | |||
| ESCd0.1||Day 0 ESCs||40.3 | |||
|- | |||
| ESCd0.2||Day 0 ESCs||56.0 | |||
|- | |||
| ESCd0.3||Day 0 ESCs||86.0 | |||
|- | |||
| DE-d3.1||Day 3 definitive endoderm||34.0 | |||
|- | |||
| DE-d3.2||Day 3 definitive endoderm||37.7 | |||
|- | |||
| DE-d3.3||Day 3 definitive endoderm||25.7 | |||
|- | |||
| NaiveESC.1||naïve ESCs cells||26.3 | |||
|- | |||
| NaiveESC.2||naïve ESCs cells||30.0 | |||
|} | |||
* ''' 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)''' | * ''' 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)''' | ||
* ''' K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)''' | * ''' K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)''' |
Revision as of 17:03, 13 March 2015
Samples: Data analysis
- Salk's Human Tissues Whole Genome Bisulfite Sequencing '
- Paper: Not out yet
- Human peripheral mononuclear cells trio - type 2 diabetes - father, mother, daughter
- Human whole blood DNA methylation study - newborn, middle-age, centarian
Samples: Data generation
- Early definitive endoderm differentiation (Song's 3-days protocol)
- {| class="wikitable"
| align="center" style="background:#f0f0f0;"|Tube ID | align="center" style="background:#f0f0f0;"|Sample | align="center" style="background:#f0f0f0;"|Concentration (QUBIT, ng/ul) |- | MA-16||H1 p54 Control TeSR||57.0 |- | MA-17||H1 p54 Activin-A||40.1 |- | AP-13||H1 p47 Control TeSR||85.0 |- | AP-14||H1 p47 BMP-4||49.4 |- | ESCd0.1||Day 0 ESCs||40.3 |- | ESCd0.2||Day 0 ESCs||56.0 |- | ESCd0.3||Day 0 ESCs||86.0 |- | DE-d3.1||Day 3 definitive endoderm||34.0 |- | DE-d3.2||Day 3 definitive endoderm||37.7 |- | DE-d3.3||Day 3 definitive endoderm||25.7 |- | NaiveESC.1||naïve ESCs cells||26.3 |- | NaiveESC.2||naïve ESCs cells||30.0 |}
- 10 MDS patients, known genotypes, (w/ Tiffany from Dr. Bejar's Lab)
- K562 cell lines: TET2 knockout (2), DNMT3a knockout (2), wildtype (2), (w/ Tiffany from Dr. Bejar's Lab)